The Dawn of Mobile Apps for Clinical Trials

In recent years, the FDA issued a guidance called Mobile Medical Applications that provides a clearer understanding around the FDA's regulations on mobile apps and how the industry should continue to follow through with best practices around validation and risk assessment.

The FDA guidance is split into six separate sections and provides examples of the differences between mobile apps and mobile medical apps.

However, as technology continues to change and advance, we can expect the FDA to advance regulations and help the industry remain compliant.

Learn more about mobile apps in clinical trials. Download the white paper now.